Tabs
FDA Center:
CDER
Time Period:
January 1, 2007 - May 31, 2013
Study Type:
Modular Program
Assessment Type:
Exploratory Analyses
Population / Cohort:
All individuals with pre-existing testosterone use
Data Sources:
Mini-Sentinel Distributed Database (MSDD)